Evidence map›Paper›PMID 37400561›Full record

Trial reportScientific reports2023

The cost-effectiveness of home phototherapy for hyperbilirubinemia in neonates: results from a randomized controlled trial.

Miriam Pettersson, Linda Ryen, Mats Eriksson, Andreas Ohlin

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03536078 (Home Phototherapy for Term Newborns With Icterus, a Clinical Randomized Blinded Trial), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03536078 nacompletednot on this map

Home Phototherapy for Term Newborns With Icterus, a Clinical Randomized Blinded Trial

TypeinterventionalSponsorRegion Örebro CountyRan2016 to 2019Enrolled147ConditionsNeonatal HyperbilirubinemiaArmshome phototherapy
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miriam PetterssonDepartment of Paediatrics, Faculty of Medicine and Health, Örebro University, 701 82, Örebro, Sweden. miriam.pettersson@regionorebrolan.se.
Linda RyenUniversity Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Mats ErikssonDepartment of Paediatrics, Faculty of Medicine and Health, Örebro University, 701 82, Örebro, Sweden.
Andreas OhlinDepartment of Paediatrics, Faculty of Medicine and Health, Örebro University, 701 82, Örebro, Sweden.
Örebro University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to establish the cost-effectiveness of home phototherapy versus hospital phototherapy treating hyperbilirubinemia in neonates more than 36 weeks. Based on clinical results from a randomised controlled trial showing that home phototherapy for hyperbilirubinemia in term neonates is as effective as hospital phototherapy, we performed a cost-minimisation analysis to identify the most cost-effective alternative. We included costs for health care resource use as well as costs for transportation in connection with re-visits. The cost per patient was €337 for home phototherapy compared with €1156 for the hospital alternative indicating average cost savings of €819 (95% confidence interval €613-1025) or 71% per patient. Transportation and outpatient costs were higher in the home treatment group and hospital care costs were higher in the hospital group. Sensitivity analysis shows that results are robust also when allowing for uncertainty. Home phototherapy for neonates more than 36 weeks costs less than in-hospital phototherapy while being equally effective, meaning that home phototherapy is a cost-effective alternative to hospital treatment for infants with neonatal hyperbilirubinemia.Trial registration NCT03536078 . Date of registration: 24/05/2018.

Indexed as

BilirubinHyperbilirubinemia, NeonatalCost-Benefit AnalysisHumansHyperbilirubinemiaInfant, NewbornPhototherapyTreatment OutcomeBilirubin

Identifiers

PMID37400561
PMCPMC10317991
OpenAlexW4382938978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.